Details of the Drug Formulaction

General Information of Drug Formulation (ID: F02005)

• Formulation Name: Atorvastatin 20 mg tablet
• Company: Cambridge Therapeutics Technologies; Sandoz

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Atorvastatin	(DMF28YC)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carboxymethylcellulose sodium	(E00621)	Not Available	Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Glycerin	(E00026)	753	Antimicrobial preservative; Emollient; Flavoring agent; Humectant; Lubricant; Plasticizing agent; Solvent; Suppository base; Tonicity agent; Viscosity-controlling agent
Magnesium stearate	(E00208)	11177	lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Tromethamine	(E00125)	6503	Alkalizing agent; Buffering agent; Emulsifying agent